JavaScript is disabled for your browser. Some features of this site may not work without it.
Statistics
Total Visits
| Views | |
|---|---|
| Olanzapine: ... | 217 |
| Olanzapine: ...(legacy) | 95 |
Total Visits Per Month
| January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | |
|---|---|---|---|---|---|---|---|
| Olanzapine: ... | 12 | 10 | 6 | 6 | 5 | 7 | 1 |
File Visits
| Views | |
|---|---|
| Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics.pdf | 5 |
| Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics.pdf(legacy) | 4 |
Top country views
| Views | |
|---|---|
| Australia | 185 |
| United States | 76 |
| China | 12 |
| United Kingdom | 7 |
| Ireland | 3 |
| Switzerland | 2 |
| Germany | 2 |
| Russia | 2 |
| Sweden | 2 |
| France | 1 |
Top cities views
| Views | |
|---|---|
| Sydney | 185 |
| Fairfield | 22 |
| Shenzhen | 9 |
| Wilmington | 5 |
| Mountain View | 4 |
| San Mateo | 4 |
| Alexandria | 3 |
| Cupertino | 3 |
| Dublin | 3 |
| Richmond | 3 |
Share
